Ledger.Open graph →
SEC Form D · Amendment · filed October 12, 2018

Immutrix Therapeutics, Inc

Offering
$16.0M
Sold
$5.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
RAPID CITY, SD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Leroy A. Ketel · Rapid City, SDExec · DirectorCarol A. Rae · Rapid City, SDExec · DirectorBrent A. Phillips · Rapid City, SDDirectorVincent R. O'Donnell · Auburndale, MADirectorEdwin V. Finch · Birmingham, ALExec · DirectorJoan B. Berkowitz · New York, NYExec · DirectorKarla Bodden · George Town, Grand Cayman, Cayman IslandsDirectorJonathan Crowther · Grand Cayman, Cayman IslandsExec · DirectorEdward Herring · Dallas, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗